The Comparison of Cognition, Depression and Anxiety, and Quality of Life After Hip Fracture Surgery Under General or Regional Anesthesia

The Comparison of Cognitive Function, Symptoms of Depression and Anxiety, and Quality of Life in Patients After Hip Fracture Surgery Under General or Regional Anesthesia

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04518839

Enrollment

140

Registered

2020-08-19

Start date

2020-08-31

Completion date

2021-09-30

Last updated

2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety, Hip Fractures, Postoperative Cognitive Dysfunction, Quality of Life

Keywords

hip fracture surgery, regional anaesthesia, general anaesthesia, postoperative cognitive dysfunction, depression, anxiety, quality of life

Brief summary

Postoperative cognitive dysfunction is a relatively common in elderly patients after hip surgery, but exact mechanism of its onset is still unclear as well as contributing factors. There is also increased incidence of depression and anxiety. Both affect the recovery after surgery, slow it down and reduce the quality of life. Patients will be divided into two groups, operated under regional anaesthesia and operated under general anaesthesia, and monitored after surgery. Patients will be tested before and after surgery to evaluate postoperative cognitive deficits, depression and anxiety scale and health-related quality of life questionnaire.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Inclusion criteria

* Patients intended for surgical treatment of hip fractures ≥ 60 years * Patients who are category ASA I to ASA III will be included in research * Sufficient cognitive ability * Only those patients who have agreed to be participants in the research and have signed the consent for participation and informed consent.

Exclusion criteria

* Patients who refused to participate in the survey and who did not sign informed consent * Patients with ASA IV or more * Patients under 60 years * Severe psychiatric disorders involving the use of psychopharmaceuticals back three months * All patients who have other fractures in addition to hip fractures * Polytrauma * All patients scheduled for more than one surgical intervention during the procedure, or within the next 8 weeks * Patients who have been diagnosed with dementia, and / or are receiving anti-dementia drugs

Design outcomes

Primary

Measure	Time frame	Description
change in cognition	preoperatively/postoperative follow up 2 months	MoCA scale (Montreal Cognitive Assessment), F-A-S test
change in anxiety and depression	preoperatively/postoperative follow up 2 months	The HAD Scale (The Hospital Anxiety and Depression Scale)
change in quality of life	preoperatively/postoperative follow up 2 months	EQ-5D-5L Questionnaire

Contacts

Primary ContactTea Fabijanić, MD

tea.fabijan@gmail.com00385915698801

Outcome results